ERCROS SA

Overview

ERCROS SA is an active pharmaceutical ingredient (API) supplier with 9 active FDA Type II Drug Master Files, covering ERYTHROMYCIN BASE; ERYTHROMYCIN BASE DIHYDRATE; ERYTHROMYCIN ETHYLSUCCINATE; FAMOTIDINE; FOSFOMYCIN PHENYLAMMONIUM SALT; FOSFOMYCIN SODIUM.

Core services & business areas

Active pharmaceutical ingredients supplied

Substances ERCROS SA is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

ERCROS SA holds 9 active (11 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ERYTHROMYCIN BASE DIHYDRATEActive2022-09-14
• FOSFOMYCIN TROMETHAMINEActive2017-02-24
• FUSIDIC ACIDActive2007-04-27
• SODIUM FUSIDATEActive2007-03-29
• FOSFOMYCIN SODIUMActive1999-08-04
• ERYTHROMYCIN BASEActive1998-09-01
• ERYTHROMYCIN ETHYLSUCCINATEActive1998-09-01
• FAMOTIDINEActive1998-07-21
• FOSFOMYCIN PHENYLAMMONIUM SALTActive1995-07-10
• LOVASTATINInactive2004-01-05
• ERYTHROMYCIN ESTOLATEInactive1998-09-01

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to ERCROS SA in our records. PharmaTek screens the full directory against live FDA enforcement data.